Literature DB >> 21115089

Volume reduction of ventromedial prefrontal cortex in bipolar II patients with rapid cycling: a voxel-based morphometric study.

Kosuke Narita1, Masashi Suda, Yuichi Takei, Yoshiyuki Aoyama, Takehiko Majima, Masaki Kameyama, Hirotaka Kosaka, Makoto Amanuma, Masato Fukuda, Masahiko Mikuni.   

Abstract

Although rapid cycling (RC), a course specifier of bipolar I or II disorder, is particularly common among bipolar II patients compared with bipolar I patients, the pathophysiological lines of evidence regarding bipolar II with RC are still limited. In this preliminary study with a cross-sectional design, we examined the regional gray matter (GM) volume in 14 bipolar II patients with RC, 17 patients without RC and 84 healthy controls by whole-brain and region-of-interest (ROI) analysis methods, using magnetic resonance imaging with voxel-based morphometry. Whole-brain analysis in this study revealed that the bipolar II patients with RC showed GM volume reductions in the bilateral hemispheres of the medial orbital prefrontal cortex, ventromedial prefrontal cortex, anterior cingulate, insula and parahippocampus, in the left hemisphere of the inferior temporal cortex and cerebellum, and in the brainstem, compared with the healthy controls. Moreover, ROI analysis focusing on the ventral prefrontal cortex, i.e., Brodmann areas 10, 11 and 47, revealed that the bipolar II patients with RC showed GM volume reduction in the ventromedial prefrontal cortex, compared with the patients without RC. The findings of our pilot study suggest that the ventromedial prefrontal cortex is associated with the generation of RC in bipolar II disorder.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21115089     DOI: 10.1016/j.pnpbp.2010.11.030

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  7 in total

1.  Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors.

Authors:  Camila O Arent; Samira S Valvassori; Gabriel R Fries; Laura Stertz; Camila L Ferreira; Jéssica Lopes-Borges; Edemilson Mariot; Roger B Varela; Felipe Ornell; Flávio Kapczinski; Monica L Andersen; João Quevedo
Journal:  Mol Neurobiol       Date:  2011-03-22       Impact factor: 5.590

2.  Cerebellum and Emotion in Social Behavior.

Authors:  Silvia Clausi; Libera Siciliano; Giusy Olivito; Maria Leggio
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Gray matter volumes in symptomatic and asymptomatic offspring of parents diagnosed with bipolar disorder.

Authors:  Lindsay C Hanford; Geoffrey B Hall; Luciano Minuzzi; Roberto B Sassi
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-01-14       Impact factor: 4.785

4.  Neurochemical metabolites in the medial prefrontal cortex in bipolar disorder: A proton magnetic resonance spectroscopy study.

Authors:  Osman Ozdel; Demet Kalayci; Gülfizar Sözeri-Varma; Yilmaz Kiroğlu; Selim Tümkaya; Tugçe Toker-Uğurlu
Journal:  Neural Regen Res       Date:  2012-12-25       Impact factor: 5.135

5.  White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder.

Authors:  Sarah W Yip; Rebecca A Chandler; Robert D Rogers; Clare E Mackay; Guy M Goodwin
Journal:  Neuroimage Clin       Date:  2013-08-13       Impact factor: 4.881

6.  Identification of bipolar disorder using a combination of multimodality magnetic resonance imaging and machine learning techniques.

Authors:  Hao Li; Liqian Cui; Liping Cao; Yizhi Zhang; Yueheng Liu; Wenhao Deng; Wenjin Zhou
Journal:  BMC Psychiatry       Date:  2020-10-06       Impact factor: 3.630

7.  Comparison of Cerebellar Grey Matter Alterations in Bipolar and Cerebellar Patients: Evidence from Voxel-Based Analysis.

Authors:  Michela Lupo; Giusy Olivito; Andrea Gragnani; Marco Saettoni; Libera Siciliano; Corinna Pancheri; Matteo Panfili; Marco Bozzali; Roberto Delle Chiaie; Maria Leggio
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.